Parkinson's Disease Genetics Database

Stopped early

Conditions studied: Parkinson's Disease

In brief

The goal of the study is to develop and organize an effort to identify genes that determine an individual's risk for developing Parkinson's disease (PD). 1. To ascertain, study and establish a repository of DNA samples that will allow for the identification of known and yet-to-be-identified genetic markers associated with the development of PD. 2. To create a database with clinical, genetic (HLA, genome screen) and medical history information that will facilitate the search for PD susceptibility genes. 3. To provide a centralized DNA repository to allow for targeted studies of genetic factors contributing to the onset, heterogeneity and progression of PD. 4. To evaluate opportunities to extend the results of research to develop methods of risk prediction, prevention and therapy for PD.

Key facts

Study ID

NCT00855556

Run by

Northwell Health

People needed

16

Starts

2008-02-01

Expected to finish

2013-02-01

Last updated by the study team

2015-09-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must have a diagnosis of Parkinson's Disease as determined by standard neurological criteria.
• Patients ≥18 years of age who are able to provide informed consent
• Patients ≥ 18 who are decisionally impaired for whom informed consent can be obtained by a legally authorized representative.

You may not qualify if…

• Patients without a diagnosis of Parkinson's Disease.

Where it is running

• The Feinstein Institute for Medical Research — Manhasset, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.